REACH Orphan Substances Consortium (Private limited company)

ROSC
BE 0630.838.609 Active ●Haverstraat 8, 2350 Vosselaar

REACH Orphan Substances Consortium is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0630.838.609. It was founded on 21-05-2015. Its registered office is in Vosselaar. Its main activity is: Other professional, scientific and technical activities. Its annual accounts for 2025 report equity of € 6 200. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 10-10-2026.

Company information

Status
Active
Enterprise number
BE 0630.838.609
VAT registered
Yes
Founded
21-05-2015
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Haverstraat 8, 2350 Vosselaar
Main activity
Other professional, scientific and technical activities
NACE activities
74999 Autres activités des professions libérales et autres activités scientifiques et techniques, nca
82990 Autres activités de service de soutien aux entreprises nca

Key figures of REACH Orphan Substances Consortium

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
----
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 6 2000 %€ 6 2000 %€ 6 2000 %€ 6 200
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 191 073+19 %€ 1 002 447-9 %€ 1 095 984-14 %€ 1 269 880
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -6 176-232 %€ -1 861-10 %€ -1 694€ 2 361
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Vosselaar.

CompanyTown
SPIJKERSCRIPT 2350 Vosselaar
GLOBAL TRANSLATIONS 2350 Vosselaar
JV Agency 2350 Vosselaar
GRAPH!Cd'SIGN 2350 Vosselaar
D'ELFINO 2350 Vosselaar
S-QURE 2350 Vosselaar
DEDEREN 2350 Vosselaar
Always Awake 2350 Vosselaar
Looking for more information about REACH Orphan Substances Consortium?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is REACH Orphan Substances Consortium still active? Yes. The Crossroads Bank for Enterprises lists REACH Orphan Substances Consortium as active.

What is the VAT number of REACH Orphan Substances Consortium? The VAT number of REACH Orphan Substances Consortium is BE 0630.838.609.

When was REACH Orphan Substances Consortium founded? REACH Orphan Substances Consortium was founded on 21-05-2015.

What is the address of REACH Orphan Substances Consortium? The current registered office of REACH Orphan Substances Consortium is Haverstraat 8, 2350 Vosselaar.

When did REACH Orphan Substances Consortium last file annual accounts? The latest annual accounts of REACH Orphan Substances Consortium were filed on 30-07-2026.

Does REACH Orphan Substances Consortium file its annual accounts on time? Yes. REACH Orphan Substances Consortium filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is REACH Orphan Substances Consortium financially healthy? Addrly gives REACH Orphan Substances Consortium a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

What is the equity of REACH Orphan Substances Consortium? The equity of REACH Orphan Substances Consortium was € 6 200 at the close of the 2025 financial year.

Who are the directors of REACH Orphan Substances Consortium? The annual accounts of REACH Orphan Substances Consortium record 1 mandate. The name, role and dates are visible with a free account.

Can REACH Orphan Substances Consortium receive Peppol e-invoices? Yes. REACH Orphan Substances Consortium is registered on the Peppol network and can receive structured electronic invoices.

What does REACH Orphan Substances Consortium do? The main activity of REACH Orphan Substances Consortium is: Other professional, scientific and technical activities.

Sources

How Addrly builds and refreshes this data